TLF
Meaning of TLF: A laboratory-made copy of a milk protein, promoted against kidney and lung cancer until the late trials came back negative.
Definition of TLF
TLF stands for talactoferrin alfa, a manufactured version of human lactoferrin, an iron-binding protein found in milk, tears and other secretions. Taken by mouth, it was designed to act on immune cells in the lining of the gut rather than to enter the bloodstream. It was tested in kidney cancer, lung cancer and severe infection, and development stopped after late trials showed no benefit.
What does natural lactoferrin do?
It is part of the body's first line of defense, present in milk and heavily concentrated in the first milk after birth, and also in tears, saliva and mucus. Neutrophils, the most numerous white cells, carry it in their granules and release it where they meet bacteria. Its best-understood trick is simple starvation: it grips iron so tightly that invading bacteria cannot obtain the iron they need to multiply. It also disturbs bacterial surfaces directly and nudges immune cells toward a response. Reading about lactoferrin in that role is quite different from reading about it as a drug.
How was the drug meant to work?
| Property | Human lactoferrin | Talactoferrin alfa |
|---|---|---|
| Origin | Milk, tears, white cell granules | Grown in a fungus by genetic engineering |
| Protein sequence | Human | Identical to human |
| Sugar attachments | Human pattern | Fungal pattern, so not an exact copy |
| Intended role | Innate defense | Rousing immune cells in the gut wall |
The design was unusual. Rather than reaching a tumor, the swallowed protein was meant to stay in the gut and act on the patches of immune tissue in its wall, waking the cells that present targets to the rest of the immune system so that an attack would then be mounted elsewhere in the body.
Why did development stop?
Early studies in advanced kidney cancer and in lung cancer produced encouraging signals, which is common at that stage and often does not survive a larger test. It did not survive here. A late-stage trial in advanced lung cancer failed to show that people lived longer, and a separate trial in severe bloodstream infection was halted early because more deaths occurred among those receiving the protein than among those receiving placebo. No regulator has approved it for any use, and the abbreviation now appears mainly in older reference material describing it as a treatment under study.
Also known as
Used in a sentence
TLF was administered as an oral solution under the trial protocol.
Good to know
Talactoferrin was never approved anywhere, and its development ended after a late-stage lung cancer trial missed its endpoint and a trial in severe infection was stopped early for excess deaths in the treated group.